Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21,219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Nguyen NH, Luo J, Paul P, Kim J, Syal G, Ha C, Rudrapatna V, Park S, Parekh N, Zheng K, Sauk JS, Limketkai B, Fleshner P, Eisenstein S, Ramamoorthy S, Melmed G, Dulai PS, Boland BS, Mahadevan U, Sandborn WJ, Ohno-Machado L, McGovern D, Singh S. Nguyen NH, et al. Among authors: luo j. Clin Gastroenterol Hepatol. 2023 Jan;21(1):173-181.e5. doi: 10.1016/j.cgh.2022.05.008. Epub 2022 May 27. Clin Gastroenterol Hepatol. 2023. PMID: 35644340 Free PMC article.
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Gu P, Luo J, Kim J, Paul P, Limketkai B, Sauk JS, Park S, Parekh N, Zheng K, Rudrapatna V, Syal G, Ha C, McGovern DP, Melmed GY, Fleshner P, Eisenstein S, Ramamoorthy S, Dulai PS, Boland BS, Grunvald E, Mahadevan U, Ohno-Machado L, Sandborn WJ, Singh S. Gu P, et al. Among authors: luo j. Am J Gastroenterol. 2022 Oct 1;117(10):1639-1647. doi: 10.14309/ajg.0000000000001855. Epub 2022 Jun 7. Am J Gastroenterol. 2022. PMID: 35973139
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study.
Singh S, Kim J, Luo J, Paul P, Rudrapatna V, Park S, Zheng K, Syal G, Ha C, Fleshner P, McGovern D, Sauk JS, Limketkai B, Dulai PS, Boland BS, Eisenstein S, Ramamoorthy S, Melmed G, Mahadevan U, Sandborn WJ, Ohno-Machado L. Singh S, et al. Among authors: luo j. Clin Gastroenterol Hepatol. 2023 Aug;21(9):2359-2369.e5. doi: 10.1016/j.cgh.2022.10.029. Epub 2022 Nov 5. Clin Gastroenterol Hepatol. 2023. PMID: 36343846
Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study.
Holmer AK, Luo J, Russ KB, Park S, Yang JY, Ertem F, Dueker J, Nguyen V, Hong S, Zenger C, Axelrad JE, Sofia A, Petrov JC, Al-Bawardy B, Fudman DI, Llano E, Dailey J, Jangi S, Khakoo N, Damas OM, Barnes EL, Scott FI, Ungaro RC, Singh S; Rising Educators Academics and Clinicians Helping-IBD (REACH-IBD). Holmer AK, et al. Among authors: luo j. Clin Gastroenterol Hepatol. 2023 Jun;21(6):1598-1606.e5. doi: 10.1016/j.cgh.2023.01.002. Epub 2023 Jan 13. Clin Gastroenterol Hepatol. 2023. PMID: 36642291
21,219 results
You have reached the last available page of results. Please see the User Guide for more information.